SEARCH RESULTS FOR: "Tag: NBIX"
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(1)
ARTICLES/BLOGS
2019(4)
2018(3)
2017(4)
2016(2)
2015(4)
CATEGORIES
Analyst Update(4)
Analyst Upgrades(1)
Buzz Stocks(4)
Expectational Analysis(1)
General(1)
Intraday Option Activity(1)
Midday Market Check(2)
Opening View(2)
Stock Market News(1)
Stocks On the Move(2)

12/2/2019 9:56 AM
The shares of Canada-based biotech Xenon Pharmaceuticals Inc (NASDAQ:XENE) are skyrocketing this morning, up 8.4% at $12.83, pacing for a new 14-month high. This pop comes after the firm said it plan...
4/22/2019 1:23 PM
Although healthcare stocks just wrapped up a brutal week amid concerns about potential policy shifts in Washington, D.C., analysts are waxing optimistic on a pair of biotech stocks today. More specif...
3/6/2019 9:54 AM
The shares of Voyager Therapeutics Inc (NASDAQ:VYGR) jumped out of the gate, after Cantor Fitzgerald initiated coverage with an "outperform" rating and a $27 price target -- a 52% premium to last nig...
1/29/2019 9:45 AM
The shares of Voyager Therapeutics Inc (NASDAQ:VYGR) are up 44% to trade at $11.58 this morning, after the gene therapy specialist inked a development deal with Neurocrine Biosciences (NBIX). The deal...
12/12/2018 10:52 AM
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) are down 21% at $67.77, after the company said its Tourette's drug failed a mid-stage trial. The dramatic early drop sent NBIX stock to a new an...
Partner Center